OCGN Q2 2025 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+20.3% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$14M-1004.7% margin

Net Income

-$15M-1073.5% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-7.3%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$54M

Total Liabilities

$51M

Stockholders' Equity

$3M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$1M	+20.3%
Gross Profit	$1M	$1M	+20.3%
Operating Income	-$14M	-$15M	+10.7%
Net Income	-$15M	-$15M	+3.5%